Feed EXPO
EX

Exponent, Inc. EXPO · NASDAQ

$71.85 -0.59% (-$0.43)

Summary

73 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 18 USD is left as net profit.
  • It earns 18 USD a year on every 100 USD of invested capital.
  • It has raised its dividend 6 years in a row and pays out only 52% of profit.

What to watch

  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $71.85
5-year average P/E 46.7 34% lower
P/E today 30.8
Engineering & Construction industry median
P/E today 30.8

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 30.8 USD for 1 USD of yearly profit. Over the last five years it was 46.7 USD on average.

Valuation in detail

Is it growing?

Slowly

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 7.8% a year over 5 years. Over the last 3 years it grew by 4.3% a year. Earnings per share grew by 1.8% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (Engineering & Construction) 4.3 USD

Out of every 100 USD of revenue, 18 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Small, stretched
Yield
1.70%
Paid out of profit
52%
Raised in a row
6 years

You receive $1.23 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $72 is at today's price. 75% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Engineering And Other Scientific brings in 85% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.